Kane Biotech Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KNBIF research report →
Price Chart
About the company
Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company's diverse product lineup includes pet dental care solutions under the StrixNB and bluestem brands, as well as DispersinB for treating wounds in both animals and humans.
- CEO
- Robert Huizinga
- IPO
- 2007
- Employees
- 20
- HQ
- Winnipeg, MB, CA
Get TickerSpark's AI analysis on KNBIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.79M
- P/E
- -2.05
- PEG
- 0.07
- P/S
- 158.88
- P/B
- -6.19
- EV/EBITDA
- -2.36
- Div Yield
- 0.00%
- Gross Margin
- -503.12%
- Op Margin
- -8113.83%
- Net Margin
- -6980.20%
- ROE
- 273.53%
- ROIC
- -312.58%
Latest fiscal year · YoY change
- Revenue
- $427.52K-79.5%
- Gross Profit
- $-163,243-118.7%
- Op Income
- $-3,109,787.2
- Net Income
- $-2,719,021-144.6%
- EPS
- $-0.02+29.2%
- OCF Growth
- +20.9%
- FCF Growth
- +22.5%
- 52W High
- $0.03
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.02
- Beta
- 0.31
- RSI (14)
- 47
- Avg Volume
- 134.32K
No earnings-call transcripts are available for KNBIF yet.
- Free Float
- 51.3%
- Shares Outstanding
- 205.06M
- Float Shares
- 105.14M
Our KNBIF coverage
Recent articles, reports, and earnings notes.
No research on KNBIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KNBIF report →Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026
globenewswire.com · Oct 7
Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Transcript
seekingalpha.com · Sep 16
Kane Biotech to Host Commercial Update Webcast on September 16
globenewswire.com · Sep 9
Kane Biotech Announces Second Quarter 2026 Financial Results
globenewswire.com · Aug 27
Kane Biotech Announces Engagement of DNA Advisors
globenewswire.com · Aug 5
Kane Biotech Announces Results of Annual and Special Meeting of Shareholders
globenewswire.com · Jul 2
Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com · Jun 24
Kane Biotech Announces Grant of Stock Options
globenewswire.com · May 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.